ES2159380T3 - Compuestos de (n-(piridinilmetil)-heterociclo)ilidenamina como agentes que se unen al receptor nicotinico de acetilcolina. - Google Patents
Compuestos de (n-(piridinilmetil)-heterociclo)ilidenamina como agentes que se unen al receptor nicotinico de acetilcolina.Info
- Publication number
- ES2159380T3 ES2159380T3 ES97309220T ES97309220T ES2159380T3 ES 2159380 T3 ES2159380 T3 ES 2159380T3 ES 97309220 T ES97309220 T ES 97309220T ES 97309220 T ES97309220 T ES 97309220T ES 2159380 T3 ES2159380 T3 ES 2159380T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- piridinilmetil
- ilidenamine
- acetilcoline
- heterociclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- -1 PYRIDINYLMETHYL Chemical class 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 206010009887 colitis Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 229960002715 nicotine Drugs 0.000 abstract 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
UN COMPUESTO (N (PIRIDINILMETIL) HETEROCICLICOS)ILIDENEAMINA DE LA FORMULA DONDE R 3 , A Y B SE DESCRIBEN MAS ADELA NTE, Y SUS SALES Y PROFARMACOS FARMACEUTICAMENTE ACEPTABLES. LOS COMPUESTOS DE LA FORMULA I Y SUS SALES Y PROFARMACOS FARMACEUTICAMENTE ACEPTABLES SON UTILES EN EL TRATAMIENTO DE TRASTORNOS ADICTIVOS, TALES COMO EL USO DEL TABACO Y OTROS PRODUCTOS QUE CONTIENEN NICOTINA, TRASTORNOS NEUROLOGICOS Y MENTALES TALES COMO LA DEMENCIA SENIL DE TIPO ALZHEIMER, ENFERMEDAD DE PARKINSON, TRASTORNO DE ATENCION DE HIPERACTIVIDAD, ANSIEDAD, OBESIDAD, SINDROME DE TOURETTE Y COLITIS ULCEROSA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3803697P | 1997-02-06 | 1997-02-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2159380T3 true ES2159380T3 (es) | 2001-10-01 |
Family
ID=21897750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97309220T Expired - Lifetime ES2159380T3 (es) | 1997-02-06 | 1997-11-17 | Compuestos de (n-(piridinilmetil)-heterociclo)ilidenamina como agentes que se unen al receptor nicotinico de acetilcolina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6020335A (es) |
EP (1) | EP0857725B1 (es) |
JP (2) | JP3542893B2 (es) |
AT (1) | ATE203535T1 (es) |
CA (1) | CA2220438C (es) |
DE (1) | DE69705817T2 (es) |
DK (1) | DK0857725T3 (es) |
ES (1) | ES2159380T3 (es) |
GR (1) | GR3036626T3 (es) |
PT (1) | PT857725E (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198803C (zh) * | 1999-03-05 | 2005-04-27 | 第一三得利制药株式会社 | 具有激活烟碱性乙酰胆碱α4β2受体作用的杂环化合物 |
JP2001302635A (ja) * | 2000-04-21 | 2001-10-31 | Suntory Ltd | 新規複素環化合物 |
ES2254611T3 (es) * | 2001-05-11 | 2006-06-16 | Pfizer Products Inc. | Derivados de tiazol. |
US20030134844A1 (en) * | 2001-10-31 | 2003-07-17 | Pfizer Inc. | Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome |
JP2005507411A (ja) * | 2001-10-31 | 2005-03-17 | ファイザー・プロダクツ・インク | 下肢静止不能症候群の治療における、ニコチン性アセチルコリン受容体アゴニスト。 |
PL369886A1 (en) | 2001-11-30 | 2005-05-02 | Pfizer Products Inc. | Aryl fused azapolycyclic compounds |
US20030162770A1 (en) | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
DE602004023299D1 (de) | 2003-07-21 | 2009-11-05 | Pfizer Prod Inc | Nikotin abhängigkeit reduzierende heteroaryl kondensierte azapolycyclische verbindungen |
WO2006006071A1 (en) * | 2004-07-07 | 2006-01-19 | Pfizer Products Inc. | Resolution of an aryl-fused azapolycyclic compound |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
LT1951663T (lt) * | 2005-11-24 | 2016-11-10 | Dompé Farmaceutici S.P.A. | (r)-arilalkilamino dariniai ir juos turinčios farmacinės kompozicijos |
JP2010523587A (ja) | 2007-04-02 | 2010-07-15 | パーキンソンズ インスティテュート | 治療処置の副作用の低減のための方法および組成物 |
US20100233503A1 (en) * | 2009-03-13 | 2010-09-16 | Zachman Joseph M | Panel for a storage container |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6230780A (ja) * | 1985-04-17 | 1987-02-09 | Ss Pharmaceut Co Ltd | 1,7−ナフチリジン誘導体及びこれを含有する薬剤 |
US5814645A (en) * | 1993-03-24 | 1998-09-29 | Bayer Aktiengesellschaft | Arylor hetaryl substituted nitrogen heterocycles and their use as pesticides |
DE4417742A1 (de) * | 1994-05-20 | 1995-11-23 | Bayer Ag | Nicht-systemische Bekämpfung von Parasiten |
-
1997
- 1997-11-04 US US08/963,852 patent/US6020335A/en not_active Expired - Fee Related
- 1997-11-07 CA CA002220438A patent/CA2220438C/en not_active Expired - Fee Related
- 1997-11-10 JP JP30745597A patent/JP3542893B2/ja not_active Expired - Fee Related
- 1997-11-17 DE DE69705817T patent/DE69705817T2/de not_active Expired - Fee Related
- 1997-11-17 PT PT97309220T patent/PT857725E/pt unknown
- 1997-11-17 ES ES97309220T patent/ES2159380T3/es not_active Expired - Lifetime
- 1997-11-17 DK DK97309220T patent/DK0857725T3/da active
- 1997-11-17 AT AT97309220T patent/ATE203535T1/de not_active IP Right Cessation
- 1997-11-17 EP EP97309220A patent/EP0857725B1/en not_active Expired - Lifetime
-
2001
- 2001-09-17 GR GR20010401484T patent/GR3036626T3/el not_active IP Right Cessation
-
2004
- 2004-02-12 JP JP2004034888A patent/JP2004175809A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ATE203535T1 (de) | 2001-08-15 |
EP0857725A1 (en) | 1998-08-12 |
US6020335A (en) | 2000-02-01 |
PT857725E (pt) | 2001-11-30 |
GR3036626T3 (en) | 2001-12-31 |
CA2220438C (en) | 2005-08-16 |
DK0857725T3 (da) | 2001-09-24 |
DE69705817D1 (de) | 2001-08-30 |
JPH10226684A (ja) | 1998-08-25 |
DE69705817T2 (de) | 2001-11-08 |
MX9709164A (es) | 1998-09-30 |
CA2220438A1 (en) | 1998-08-06 |
EP0857725B1 (en) | 2001-07-25 |
JP3542893B2 (ja) | 2004-07-14 |
JP2004175809A (ja) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2159380T3 (es) | Compuestos de (n-(piridinilmetil)-heterociclo)ilidenamina como agentes que se unen al receptor nicotinico de acetilcolina. | |
AR003453A1 (es) | Inhibidores de agregado de plaquetas, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene y procedimiento para la preparacion de dichos inhibidores | |
PA8472301A1 (es) | Derivados de isotiazol utiles como agentes anticancerosos | |
DK1196397T3 (da) | Metabotrope glutamatreceptorantagonister og anvendelse deraf til behandling af sygdomme i centralnervesystemet | |
BG104561A (en) | Aryl fused azapolycyclic compounds | |
DE60032249D1 (de) | AMINO-SUBSTITUIERTE PYRAZOLOi1,5-Aö-1,5-PYRIMIDINE UND PYRAZOLOi1,5-Aö-1,3,5-TRIAZINE | |
UY26872A1 (es) | Derivados de la 4- fenil piridina | |
SE9904505D0 (sv) | Novel compounds | |
GEP20022676B (en) | 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors | |
NO20023995D0 (no) | 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse | |
SE9702564D0 (sv) | New compounds | |
AR006119A1 (es) | Compuestos de quinoxalinadionas uso de los mismos para la fabricacion de un medicamento, compuestos de quinoxalinas para producirlos y procedimiento parala preparacion de los mismos | |
NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
ES453947A1 (es) | Un procedimiento para la preparacion de nuevas imidazo (1,2-alfa) piridinas sustituidas. | |
NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
PA8527401A1 (es) | 7-oxo-piridopirimidinas (ii) | |
GT200000197A (es) | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6- morfolin-4-il-4-o tolil-piridin-3-il)-isobutiramida. | |
DK0779284T3 (da) | Hidtil ukendte 2-naphtanamidderivater og terapeutiske anvendelser heraf som agonister af D3-receptorer | |
MX9306311A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
SE9702563D0 (sv) | Compounds | |
AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
ES2152682T3 (es) | Derivados de indolina utiles como antagonistas del receptor 5ht-2c. | |
AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
CO5570673A2 (es) | Compuestos azapoliciclicos condensados con arilo | |
DK0888356T3 (da) | Kondenserede 2,3-benzodiazepinderivater og deres anvendelse som AMPA-receptohaemmere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 857725 Country of ref document: ES |